Intuitive Surgical, Inc. $ISRG Shares Purchased by Navera Investment Management Ltd.

Navera Investment Management Ltd. boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.1% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 531,818 shares of the medical equipment provider’s stock after purchasing an additional 593 shares during the period. Intuitive Surgical accounts for about 5.3% of Navera Investment Management Ltd.’s investment portfolio, making the stock its 7th biggest holding. Navera Investment Management Ltd.’s holdings in Intuitive Surgical were worth $289,052,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Chilton Capital Management LLC boosted its position in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Elite Financial Inc. acquired a new position in Intuitive Surgical during the first quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA acquired a new position in Intuitive Surgical during the first quarter valued at approximately $30,000. TD Capital Management LLC boosted its position in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. Finally, 1248 Management LLC acquired a new position in Intuitive Surgical during the first quarter valued at approximately $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $615.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Wells Fargo & Company raised their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research report on Wednesday, July 23rd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Saturday, September 27th. The Goldman Sachs Group cut their price objective on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a research report on Wednesday, October 1st. Finally, Truist Financial raised their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 23rd. Fourteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $589.43.

Intuitive Surgical Trading Down 1.9%

NASDAQ:ISRG opened at $440.94 on Wednesday. The stock has a market cap of $158.07 billion, a P/E ratio of 61.50, a PEG ratio of 4.71 and a beta of 1.61. The stock has a 50 day simple moving average of $461.55 and a 200 day simple moving average of $499.41. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm’s revenue for the quarter was up 21.4% compared to the same quarter last year. During the same period last year, the firm posted $1.78 EPS. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares of the company’s stock, valued at $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 45,224 shares of company stock valued at $21,716,492. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.